Balanced news tone
News Sentiment
TAKP34 sentiment intelligence
Takeda Pharmaceutical Company Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +7.9% over four weeks, trend inactive, and near fair-value range.
Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 11:37
- Source
- Investing.com Nigeria
Cristália-Takeda plant deal cleared in Brazil
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Jul 2026 14:46
- Source
- MLex
Takeda (NYSE: TAK) outlines FY2025 results, pipeline launches and ESG progress
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Demand shift appears to complicate Cristália-Takeda plant deal scrutiny in Brazil
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jun 2026 07:00
- Source
- MLex
Takeda Pharmaceutical Q4 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- Market source
Earnings call transcript: Takeda’s Q4 2025 performance highlights resilience
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing.com
Brazil Pharmaceutical Market Size & Outlook, 2026-2033
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 20 Apr 2026 07:00
- Source
- Grand View Research
Latin America Pharmaceutical Market Size & Growth, 2034
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- Market Data Forecast
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- BioSpace
Takeda’s dengue vaccine shows long-lasting protection
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- The Japan Times
Takeda Offers Dengue Shot Cheaper in Brazil, Indonesia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Mar 2023 08:00
- Source
- Bloomberg Línea
TWi and Takeda settle dispute over anti-reflux generic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Aug 2021 18:09
- Source
- Generics and Biosimilars Initiative
Brazil's Hypera Pharma to acquire drugs from Japan's Takeda for $825 million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Mar 2020 08:00
- Source
- Reuters
Takeda Pharmaceutical Co Ltd (TAK) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2019 20:16
- Source
- GuruFocus